NCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT07142421 2025-08-26
A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
First Affiliated Hospital of Zhejiang University
Phase 2 Active not recruiting
NCT03034473 2023-12-28
TransValid-A
University Medical Center Goettingen
Phase NA Unknown
NCT05174156 2022-07-14
Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Unknown
NCT04718701 2021-08-16
ATNPA
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04413734 2020-06-04
Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma
Zhejiang University
Phase 2 Unknown
NCT01769508 2016-06-13
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
SCRI Development Innovations, LLC
Phase 2 Terminated
NCT01226719 2015-05-27
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01379482 2014-05-06
Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer
Uppsala University
Phase 2 Completed